Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to ...
HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic ...
Please provide your email address to receive an email when new articles are posted on . Vitamin E significantly reduced serum ALT and AST in patients with MASLD. It also significantly increased MASH ...
Hosted on MSN
US FDA approves first AI tool for liver disease trials: How AIM-NASH transforms biopsy reading
The FDA has officially approved the first AI tool to help with liver disease drug trials, and it is designed to make reading liver biopsies for MASH faster, more consistent, and easier for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results